Paper29705121
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF and 1 other. Ageing Res Rev, 2018. Cited by 354 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. Papers, record 29705121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29705121
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Dysbiosis | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Parkinson Disease | Major topic |
| Animals | |
| Gastrointestinal Tract | |
| Humans | |
| Inflammation |
Source PubMed
Cited by252
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 354 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42921324 | Leveraging the Gut Microbiota for Mechanistically Informed Therapeutics against Body-First Parkinson's Disease. | ACS Bio Med Chem Au | 2026 | https://conductscience.org/library/papers/42921324 | PubMed |
| 42909340 | Gut microbial histamine and serotonin promote cerebrovascular angiogenesis: Evidence from moyamoya disease. | Genes Dis | 2027 | https://conductscience.org/library/papers/42909340 | PubMed |
| 42879046 | Gut Microbiota Modulation in CNS Disorders: Therapeutic Strategies and Implications for Drug Efficacy. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42879046 | PubMed |
| 42775205 | The Human Microbiome in Airborne Particulate Matter-Associated Aging-Related Chronic Diseases: An Evidence-Stratified Review. | Environ Health (Wash) | 2026 | https://conductscience.org/library/papers/42775205 | PubMed |
| 42766607 | Sex-based differences in the gut-metabolism axis in aging and Nrf2-deficient mice. | PLoS One | 2026 | https://conductscience.org/library/papers/42766607 | PubMed |
| 42736182 | Effects of L-threonine supplementation on growth performance, intestinal histology, gut microbiota and gene expression related to gut barrier function in broiler chickens. | Poult Sci | 2026 | https://conductscience.org/library/papers/42736182 | PubMed |
| 42576849 | From dysbiosis to dysfunction: specific gut microbes and metabolites in the pathogenesis of Parkinson's disease. | Sustain Microbiol | 2026 | https://conductscience.org/library/papers/42576849 | PubMed |
| 42522048 | Neuroinflammation in Alzheimer's and Parkinson's diseases: pathogenic mechanisms and therapeutic strategies. | Transl Neurodegener | 2026 | https://conductscience.org/library/papers/42522048 | PubMed |
| 42518164 | Probiotics and Plant Extracts in the Gut-Brain Axis: Mechanisms, Interactions, and Clinical Perspectives. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/42518164 | PubMed |
| 42400749 | Limosilactobacillus reuteri Alleviates Parkinson's Disease by Regulating CDCA Secretion. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/42400749 | PubMed |
| 42197098 | Mechanisms of Exercise-Mediated Regulation of the Gut-Brain Axis in Parkinson's Disease. | Nutrients | 2026 | https://conductscience.org/library/papers/42197098 | PubMed |
| 42154337 | The Influence of Gut Microbiome on Alpha-Synuclein Aggregation: Implications for Parkinson's Disease Pathogenesis. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42154337 | PubMed |
| 42075021 | Dietary Yam (Dioscorea opposita Thunb.) Ameliorates Parkinson's Disease in Mice via Gut Microbiota-Driven Mitochondrial Improvement and Neuroinflammation Inhibition. | Nutrients | 2026 | https://conductscience.org/library/papers/42075021 | PubMed |
| 41982910 | The role of microbiota dysbiosis in Parkinson's disease: Pathophysiology and therapeutic opportunities. | Eng Microbiol | 2025 | https://conductscience.org/library/papers/41982910 | PubMed |
| 41912775 | Fusobacterium nucleatum drives colorectal cancer progression through the circPTBP3/miR-760/PUM1 axis. | Oncogene | 2026 | https://conductscience.org/library/papers/41912775 | PubMed |
| 41907367 | Nanotherapeutic Interventions for Parkinson's Disease: Modulating Pathogenic Mechanisms and Overcoming Therapeutic Obstacles. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41907367 | PubMed |
| 41903068 | Flavonoid Rutin Reduces Intestinal Inflammation in an Experimental Model of Parkinson's Disease. | Neurotox Res | 2026 | https://conductscience.org/library/papers/41903068 | PubMed |
| 41761283 | Bacteroides coprocola protects dopaminergic neurons in rotenone-induced Parkinson's disease mouse model by modulating gut microbiota dysbiosis and inhibiting the NLRP3 signaling pathway. | Transl Neurodegener | 2026 | https://conductscience.org/library/papers/41761283 | PubMed |
| 41683938 | A Metabolites' Interplay Can Modulate DNA Repair by Homologous Recombination. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683938 | PubMed |
| 41683327 | Composition of the Gut Microbiota in Older Adults Residing in a Nursing Home and Its Association with Dementia. | Nutrients | 2026 | https://conductscience.org/library/papers/41683327 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29705121
GET https://conductscience.org/api/papers/v1/29705121/cited_by?page=2